The U.S. Conjugate Vaccine Market (2018-2023)Posted by Bharat Book on August 27th, 2018 Bharat Book Bureau Provides the Trending Market Research Report on “The U.S. Conjugate Vaccine Market (2018-2023)”under Life Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. The Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The U.S. is one of the prominent markets for conjugate vaccines. Scheduled vaccination of conjugate vaccines has eradicated health disparities and consequently, the rate of incidence of diseases in the U.S. have been lower. Native Alaskan/American Indian and African-American children had much higher rates of invasive pneumococcal diseases than white children in the U.S. Vaccination has wiped out these health disparities, and the incidence of these diseases is now relatively low across all groups. Market Segmentation: -Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others. The highest penetration among paediatrics is that of DTP vaccines. Request a free sample copy of Conjugate Vaccine Market Report @ Key growth factors: The U.S. is projected to be one of the most significant markets for conjugate vaccines during the forecast period, due to a rise in demand for pneumococcal, meningococcal vaccines, and other conjugate vaccines. Increased diagnosis and treatments would fuel the conjugate vaccines market. Recommended vaccines and dosages are updated on a regular basis to comply with prevalent serogroups of infectious agents. For example, the CDC has its own immunization schedule for U.S. citizens. This has increased the effectiveness of administered vaccines, which thereby boosts the demand for the product, leading to increase in market sales. Growing initiatives by HHS to reduce infectious diseases by increasing immunization rates and immunization recommendations will fuel the growth of the market. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases. Threats and key players: -The U.S. conjugate vaccine market is expected to grow positively. But since it is a saturated market, the scope for significant growth is limited. In North America, the population above 65 years of age has decreased from the year 2014 to 2016. So, the demand for adult vaccines has also lowered. The overall penetration rates for the adult segment, is lower than that of the pediatric segment. What’s covered in the report? 1. Overview of the U.S. conjugate vaccine market Why buy? -Understand the demand for conjugate vaccines to determine the viability of the market Browse our full report with Table of Contents : https://www.bharatbook.com/MarketReports/The-US-Conjugate-Vaccine-Market-2018-2023/1166501 About Bharat Book Bureau: Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors. Contact us at: Bharat Book Bureau Follow us on : Twitter, Facebook, LinkedIn, Google Plus Like it? Share it! More by this author |